Bistoni. F F; Baccarini. M M; Blasi. E E; Riccardi. C C; Marconi. P P; Garaci. E E
In mice, giving thymosin‑alpha‑1 at a low dose (100 µg/kg) several times over two weeks boosted the number of neutrophils in the blood and made them better at killing the fungus Candida albicans. However, a single larger dose (500 µg/kg) given three days before testing actually reduced this fungus‑killing ability. The effect depends on how much and how often the peptide is taken.
Baldassarre. A M AM; Stirparo. G G; Palamara. A T AT; Padovani. A A; Mastino. A A
In a mouse study, the peptide thymosin‑alpha‑1 caused certain immune cells to release the signaling molecule PGE2, especially in mice without a thymus and when the cells were exposed for longer periods. Normal mice didn’t show the same effect, indicating the response depends on the animal’s immune status.
Scientists made an antibody that spots a protein on mature T‑cells in cows. They found that adding thymosin‑alpha‑1 (a peptide some people take for immune support) makes more of this protein appear, showing the peptide can push T‑cells toward a mature state, at least in cow cells.
In mice without a thymus, giving them a lab-made version of thymosin‑alpha‑1 helped bring back certain immune functions that were weakened, showing the peptide can boost T‑cell related activity after it’s taken in the body.
Sorensen. R U RU; Halpin. T C TC; Abramowsky. C R CR; Hornick. D L DL; Miller. K M KM; Naylor. P P;...
This case report describes a child with severe gut‑related loss of T‑cells and a tiny thymus, who had very low levels of thymosin‑alpha‑1. Giving a thymosin‑containing preparation every day helped a bit for a short time, but weekly doses didn’t work and the T‑cell count never rose. The study suggests that simply adding thymosin‑alpha‑1 isn’t enough to rebuild the immune system when T‑cells are being lost in large amounts.
Hersh. E M EM; Mansell. P W PW; Reuben. J M JM; Rios. A A; Newell. G R GR
The study looked at immune markers in gay men with different stages of HIV infection and found that a protein called thymosin‑alpha‑1 was higher in the blood of all groups, even those without symptoms, while many other immune cells were lower as disease got worse.
Thymosin alpha‑1 is one of several peptides the thymus makes that help regulate the immune system and interact with the brain and other hormones. This review talks about what these thymic hormones do, how they’re controlled, and their potential use in people with weak or over‑active immune systems, but it doesn’t give specific dosing or how to use them in everyday health hacks.
McClure. J E JE; Lameris. N N; Wara. D W DW; Goldstein. A L AL
Scientists created a very sensitive test to measure thymosin‑alpha‑1 in blood, showing it’s stable and doesn’t break down during collection. They found the peptide is highest before birth, drops after birth, and stays fairly steady through childhood, while pregnant mothers have higher levels. This tells us the natural levels of the peptide in the body but doesn’t give dosing or performance tips.
The study shows that the natural presence of thymosin‑alpha‑1 in the thymus drops as people get older, especially after the early teens, and that the cells that normally hold it become fewer. It’s a basic tissue‑mapping paper, not a trial of taking the peptide, so it doesn’t give direct dosing or protocol advice.
Hersh. E M EM; Mansell. P W PW; Reuben. J M JM; Rios. A A; Newell. G R GR; Goldstein. A L AL; Lynch....
The study measured immune cell ratios and blood levels of thymosin‑alpha‑1 in AIDS patients and people with various cancers. It found that most AIDS patients have a low helper‑to‑suppressor (CD4/CD8) ratio and higher thymosin‑alpha‑1, and that a similar inverted ratio appears in about a third of cancer patients. However, the research is observational and doesn’t test any treatments, so it offers limited direct guidance for self‑experiments.
Dillman. R O RO; Beauregard. J C JC; Zavanelli. M I MI; Halliburton. B L BL; Wormsley. S S; Royston....
In a small study of advanced cancer patients, giving thymosin‑alpha‑1 (TA1) as a single injection helped improve some immune‑system lab tests, especially at a dose around 1.2 mg/m², but the benefits showed up quickly (within 1‑2 days) and faded after about three days. No tumor shrinkage was seen, and the peptide was well tolerated.
Cupissol. D D; Rey. A A; Goldstein. A L AL; Serrou. B B
In a mouse study, bone‑marrow cells that were briefly soaked in the peptide thymosin‑alpha‑1 were injected into the bloodstream and they slowed down the growth of a cancer tumor and helped the mice live longer. The same effect was seen with a larger thymosin mixture, but the pure peptide worked at a much lower dose. Similar drugs that looked promising in lab tests didn’t help in the mice.
Michalewsky. J J; Gabriel. T F TF; Winter. D P DP; Makofske. R R; Danho. W W; Shively. J J; Biemann....
Scientists double‑checked the exact order of the 28 amino acids that make up thymosin‑alpha‑1 using several lab techniques, confirming the sequence that was first reported years ago.
Stepien. H H; Sakura. N N; Dahmen. J J; Lundanes. E E; Rampold. G G; Folkers. K K
The researchers tested various fractions of bovine thymus extracts on mouse spleen cells to see which ones boost cell growth. They found that a crude calf thymus outer fraction was active, but the synthetic peptide thymosin‑alpha‑1 (and some other fractions) did not stimulate lymphocyte proliferation in this test.
Healy. D L DL; Hodgen. G D GD; Schulte. H M HM; Chrousos. G P GP; Loriaux. D L DL; Hall. N R NR; Gol...
In young monkeys, a mixture called thymosin fraction 5 raised stress hormones (ACTH, cortisol) and beta‑endorphin when given by IV, but the individual synthetic pieces, including thymosin‑α1, did not have this effect. Removing the thymus lowered those hormones, suggesting the thymus itself can influence the pituitary‑adrenal system during development.
In a rat study, giving both ulinastatin and the immune‑boosting peptide thymosin‑alpha‑1 after a severe infection lowered death rates, reduced organ damage, and cut down cell death in the spleen compared with giving either one alone or nothing.
The report from a vaccine summit talks about new ways to boost vaccine effectiveness, mentioning several adjuvants including thymosin-alpha-1 (also called thymalfasin). It mainly describes research and development for vaccines rather than personal health use.
Xiong. Wei W; Liu. Zhi-Gang ZG; Xiong. Lan L; Xiong. Min-Chun MC; Lei. Guo-Hua GH; Wu. Ye Y; Zhao. Q...
In people with silicosis, a lung disease caused by inhaling silica dust, the immune cells CD3+, CD4+, and CD8+ are lower than normal. Adding the peptide thymosin‑alpha‑1 (called thymalfasin) to standard treatment raised the number of CD4+ T‑cells after just one week, suggesting it can boost a specific part of the immune system in this sick group.
Abbas. Z Z; Hamid. S S SS; Tabassum. S S; Jafri. W W
In a tiny study of 11 people who didn’t get better with the usual hepatitis C drugs (interferon and ribavirin), adding a peptide called thymosin‑alpha‑1 helped most of the relapsers and one non‑responder clear the virus. Side effects were mild and no dose cuts were needed.
Bistoni. F F; Marconi. P P; Frati. L L; Bonmassar. E E; Garaci. E E
In mice, giving thymosin‑alpha‑1 before they are exposed to a deadly Candida fungus helps them survive, but giving it after infection does nothing. The benefit works at a specific dose (about 100 µg per kg) and also protects mice whose immune systems were weakened by a chemotherapy drug.